Fatty acids, obesity, and insulin resistance: Time for a reevaluation

Diabetes

Volumn 60, Issue 10, 2011, Pages 2441-2449

  Karpe, Fredrik ^a,b   Dickmann, Julian R ^a   Frayn, Keith N ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NIHR OXFORD BIOMEDICAL RESEARCH CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID;

ADIPOSE TISSUE; DIET RESTRICTION; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ADIPOSE TISSUE; DIABETES MELLITUS; FATTY ACIDS, NONESTERIFIED; HUMANS; INSULIN RESISTANCE; OBESITY;

EID: 80053408094     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db11-0425     Document Type: Review

References (84)

1. Frayn KN, Coppack SW. Insulin resistance, adipose tissue and coronary heart disease. Clin Sci (Lond) 1992;82:1-8
2. Frayn KN, Williams CM, Arner P. Are increased plasma non-esterified fatty acid concentrations a risk marker for coronary heart disease and other chronic diseases? Clin Sci (Lond) 1996;90:243-253 (Pubitemid 26097890)
3. Dole VP. A relation between non-esterified fatty acids in plasma and the metabolism of glucose. J Clin Invest 1956;35:150-154
4. Gordon RS Jr. Unesterified fatty acid in human blood plasma. II. The transport function of unesterified fatty acid. J Clin Invest 1957;36:810-815
5. Gordon RS Jr, Cherkes A. Unesterified fatty acid in human blood plasma. J Clin Invest 1956;35:206-212
6. Eaton RP, Berman M, Steinberg D. Kinetic studies of plasma free fatty acid and triglyceride metabolism in man. J Clin Invest 1969;48:1560-1579
7. Nielsen S, Guo Z, Johnson CM, Hensrud DD, Jensen MD. Splanchnic lipolysis in human obesity. J Clin Invest 2004;113:1582-1588 (Pubitemid 39071681)
8. Lafontan M, Langin D. Lipolysis and lipid mobilization in human adipose tissue. Prog Lipid Res 2009;48:275-297
9. Evans K, Burdge GC, Wootton SA, Clark ML, Frayn KN. Regulation of dietary fatty acid entrapment in subcutaneous adipose tissue and skeletal muscle. Diabetes 2002;51:2684-2690 (Pubitemid 34970919)
10. Heimberg M, Dunn GD, Wilcox G. The derivation of plasma-free fatty acids from dietary neutral fat in man. J Lab Clin Med 1974;83:393-402
11. Fielding BA, Callow J, Owen RM, Samra JS, Matthews DR, Frayn KN. Postprandial lipemia: the origin of an early peak studied by specific dietary fatty acid intake during sequential meals. Am J Clin Nutr 1996;63:36-41 (Pubitemid 26005724)
12. McQuaid SE, Hodson L, Neville MJ, et al. Downregulation of adipose tissue fatty acid trafficking in obesity: a driver for ectopic fat deposition? Diabetes 2011;60:47-55
13. Miles JM, Nelson RH. Contribution of triglyceride-rich lipoproteins to plasma free fatty acids. Horm Metab Res 2007;39:726-729 (Pubitemid 350099820)
14. Samra JS, Clark ML, Humphreys SM, Macdonald IA, Frayn KN. Regulation of lipid metabolism in adipose tissue during early starvation. Am J Physiol 1996;271:E541-E546
15. Ruge T, Hodson L, Cheeseman J, et al. Fasted to fed trafficking of Fatty acids in human adipose tissue reveals a novel regulatory step for enhanced fat storage. J Clin Endocrinol Metab 2009;94:1781-1788
16. Singer P, Gödicke W, Voigt S, Hajdu I, Weiss M. Postprandial hyperinsulinemia in patients with mild essential hypertension. Hypertension 1985;7:182-186 (Pubitemid 15093641)
17. Reaven GM, Hollenbeck C, Jeng C-Y, Wu MS, Chen Y-DI. Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 1988;37:1020-1024 (Pubitemid 19033579)
18. Kruszynska YT, Munro J, Home PD, McIntyre N. Twenty-four hour C-peptide and insulin secretion rates and diurnal profiles of glucose, lipids and intermediary metabolites in cirrhosis. Clin Sci (Lond) 1992;83:597-605
19. Bakewell L, Burdge GC, Calder PC. Polyunsaturated fatty acid concentrations in young men and women consuming their habitual diets. Br J Nutr 2006;96:93-99 (Pubitemid 44160901)
20. Shadid S, Kanaley JA, Sheehan MT, Jensen MD. Basal and insulin-regulated free fatty acid and glucose metabolism in humans. Am J Physiol Endocrinol Metab 2007;292:E1770-E1774 (Pubitemid 47084712)
21. Magkos F, Patterson BW, Mohammed BS, Klein S, Mittendorfer B. Women produce fewer but triglyceride-richer very low-density lipoproteins than men. J Clin Endocrinol Metab 2007;92:1311-1318 (Pubitemid 46556403)
22. Stefan N, Kantartzis K, Celebi N, et al. Circulating palmitoleate strongly and independently predicts insulin sensitivity in humans. Diabetes Care 2010;33:405-407
23. Soeters MR, Sauerwein HP, Groener JE, et al. Sex-related differences in the metabolic response to fasting. J Clin Endocrinol Metab 2007;92:3646-3652 (Pubitemid 47435351)
24. Marinou K, Adiels M, Hodson L, Frayn KN, Karpe F, Fielding BA. Young women partition fatty acids towards ketone body production rather than VLDL-TAG synthesis, compared with young men. Br J Nutr 2011;105:857-865
25. Schlierf G, Dorow E. Diurnal patterns of triglycerides, free fatty acids, blood sugar, and insulin during carbohydrate-induction in man and their modification by nocturnal suppression of lipolysis. J Clin Invest 1973;52:732-740
26. Taggart P, Carruthers M. Endogenous hyperlipidaemia induced by emotional stress of racing driving. Lancet 1971;1:363-366
27. Hodgetts V, Coppack SW, Frayn KN, Hockaday TDR. Factors controlling fat mobilization from human subcutaneous adipose tissue during exercise. J Appl Physiol 1991;71:445-451
28. Romijn JA, Coyle EF, Sidossis LS, et al. Regulation of endogenous fat and carbohydrate metabolism in relation to exercise intensity and duration. Am J Physiol 1993;265:E380-E391 (Pubitemid 23296552)
29. Groop LC, Bonadonna RC, DelPrato S, et al. Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. J Clin Invest 1989;84:205-213 (Pubitemid 19170111)
30. Sørensen LP, Andersen IR, Søndergaard E, et al. Basal and insulin mediated VLDL-triglyceride kinetics in type 2 diabetic men. Diabetes 2011;60:88-96
31. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963;1:785-789
32. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005;365:1415-1428 (Pubitemid 40523737)
33. Boden G, Chen X, Ruiz J, White JV, Rossetti L. Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 1994;93:2438-2446 (Pubitemid 24177157)
34. Shah PV, Vella A, Basu A, et al. Effects of free fatty acids and glycerol on splanchnic glucose metabolism and insulin extraction in nondiabetic humans. Diabetes 2002;51:301-310 (Pubitemid 34764784)
35. Roden M, Stingl H, Chandramouli V, et al. Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans. Diabetes 2000;49:701-707 (Pubitemid 30339983)
36. Staehr P, Hother-Nielsen O, Landau BR, Chandramouli V, Holst JJ, Beck-Nielsen H. Effects of free fatty acids per se on glucose production, gluconeogenesis, and glycogenolysis. Diabetes 2003;52:260-267 (Pubitemid 36173177)
37. Kruszynska YT, Mulford MI, Yu JG, Armstrong DA, Olefsky JM. Effects of nonesterified fatty acids on glucose metabolism after glucose ingestion. Diabetes 1997;46:1586-1593 (Pubitemid 27411234)
38. Wiesenthal SR, Sandhu H, McCall RH, et al. Free fatty acids impair hepatic insulin extraction in vivo. Diabetes 1999;48:766-774 (Pubitemid 29153076)
39. Fielding BA, Humphreys SM, Allman RFC, Frayn KN. Mono-, di- and triacylglycerol concentrations in human plasma: effects of heparin injection and of a high-fat meal. Clin Chim Acta 1993;216:167-173 (Pubitemid 23233119)
40. Friedberg SJ, Klein RF, Trout DL, Bogdonoff MD, Estes EHJ Jr. The incorporation of plasma free fatty acids into plasma triglycerides in man. J Clin Invest 1961;40:1846-1855
41. Hodson L, Bickerton AS, McQuaid SE, et al. The contribution of splanchnic fat to VLDL triglyceride is greater in insulin-resistant than insulin-sensitive men and women: studies in the postprandial state. Diabetes 2007;56:2433-2441 (Pubitemid 47523250)
42. Nestel PJ. Relationship between FFA flux and TGFA influx in plasma before and during the infusion of insulin. Metabolism 1967;16:1123-1132
43. Steinberg HO, Paradisi G, Hook G, Crowder K, Cronin J, Baron AD. Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. Diabetes 2000;49:1231-1238 (Pubitemid 30439100)
44. Florian JP, Pawelczyk JA. Non-esterified fatty acids increase arterial pressure via central sympathetic activation in humans. Clin Sci (Lond) 2010;118:61-69
45. Paolisso G, Tataranni PA, Foley JE, Bogardus C, Howard BV, Ravussin E. A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM. Diabetologia 1995;38:1213-1217
46. Charles MA, Eschwège E, Thibult N, et al. The role of non-esterified fatty acids in the deterioration of glucose tolerance in Caucasian subjects: results of the Paris Prospective Study. Diabetologia 1997;40:1101-1106 (Pubitemid 27381974)
47. Pankow JS, Duncan BB, Schmidt MI, et al; Atherosclerosis Risk in Communities Study. Fasting plasma free fatty acids and risk of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes Care 2004;27:77-82 (Pubitemid 38196713)
48. Il'yasova D, Wang F, D'Agostino RB Jr, Hanley A, Wagenknecht LE. Prospective association between fasting NEFA and type 2 diabetes: impact of post-load glucose. Diabetologia 2010;53:866-874
49. Byrne CD, Maison P, Halsall D, Martensz N, Hales CN, Wareham NJ. Cross-sectional but not longitudinal associations between non-esterified fatty acid levels and glucose intolerance and other features of the metabolic syndrome. Diabet Med 1999;16:1007-1015 (Pubitemid 30051427)
50. Pirro M, Mauriège P, Tchernof A, et al. Plasma free fatty acid levels and the risk of ischemic heart disease in men: prospective results from the Québec Cardiovascular Study. Atherosclerosis 2002;160:377-384 (Pubitemid 34159331)
51. Pilz S, Scharnagl H, Tiran B, et al. Free fatty acids are independently associated with all-cause and cardiovascular mortality in subjects with coronary artery disease. J Clin Endocrinol Metab 2006;91:2542-2547 (Pubitemid 44024615)
52. Charles MA, Fontbonne A, Thibult N, et al. High plasma nonesterified fatty acids are predictive of cancer mortality but not of coronary heart disease mortality: results from the Paris Prospective Study. Am J Epidemiol 2001;153:292-298 (Pubitemid 32958654)
53. Fagot-Campagna A, Balkau B, Simon D, et al. High free fatty acid concentration: an independent risk factor for hypertension in the Paris Prospective Study. Int J Epidemiol 1998;27:808-813 (Pubitemid 28504968)
54. Jouven X, Charles M-A, Desnos M, Ducimetière P. Circulating nonesterified fatty acid level as a predictive risk factor for sudden death in the population. Circulation 2001;104:756-761 (Pubitemid 32762671)
55. Yki-Järvinen H. Ectopic fat accumulation: an important cause of insulin resistance in humans. J R Soc Med 2002;95(Suppl. 42):39-45 (Pubitemid 34879130)
56. Holloway GP, Luiken JJ, Glatz JF, Spriet LL, Bonen A. Contribution of FAT/CD36 to the regulation of skeletal muscle fatty acid oxidation: an overview. Acta Physiol (Oxf) 2008;194:293-309
57. Unger RH. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes 1995;44:863-870
58. Bachmann OP, Dahl DB, Brechtel K, et al. Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans. Diabetes 2001;50:2579-2584 (Pubitemid 33642777)
59. Kelley DE. Skeletal muscle fat oxidation: timing and flexibility are everything. J Clin Invest 2005;115:1699-1702 (Pubitemid 40979705)
60. Opie LH, Walfish PG. Plasma free fatty acid concentrations in obesity. N Engl J Med 1963;268:757-760
61. James WPT. Research on Obesity: a report of the DHSS/MRC Group. London, Her Majesty's Stationery Office, 1976
62. Tan GD, Neville MJ, Liverani E, et al. The in vivo effects of the Pro12Ala PPARgamma2 polymorphism on adipose tissue NEFA metabolism: the first use of the Oxford Biobank. Diabetologia 2006;49:158-168 (Pubitemid 43151627)
63. Widjaja A, Morris RJ, Levy JC, Frayn KN, Manley SE, Turner RC. Withinand between-subject variation in commonly measured anthropometric and biochemical variables. Clin Chem 1999;45:561-566 (Pubitemid 29165967)
64. Magkos F, Patterson BW, Mittendorfer B. Reproducibility of stable isotopelabeled tracer measures of VLDL-triglyceride and VLDL-apolipoprotein B-100 kinetics. J Lipid Res 2007;48:1204-1211 (Pubitemid 46708687)
65. Hodson L, Harnden KE, Roberts R, Dennis AL, Frayn KN. Does the DASH diet lower blood pressure by altering peripheral vascular function? J Hum Hypertens 2010;24:312-319
66. Large V, Reynisdottir S, Langin D, et al. Decreased expression and function of adipocyte hormone-sensitive lipase in subcutaneous fat cells of obese subjects. J Lipid Res 1999;40:2059-2066
67. Hellström L, Reynisdottir S. Influence of heredity for obesity on adipocyte lipolysis in lean and obese subjects. Int J Obes Relat Metab Disord 2000;24:340-344 (Pubitemid 30137725)
68. Langin D, Dicker A, Tavernier G, et al. Adipocyte lipases and defect of lipolysis in human obesity. Diabetes 2005;54:3190-3197 (Pubitemid 43334374)
69. Jocken JW, Langin D, Smit E, et al. Adipose triglyceride lipase and hormone-sensitive lipase protein expression is decreased in the obese insulin-resistant state. J Clin Endocrinol Metab 2007;92:2292-2299 (Pubitemid 46997136)
70. Mittendorfer B, Magkos F, Fabbrini E, Mohammed BS, Klein S. Relationship between body fat mass and free fatty acid kinetics in men and women. Obesity (Silver Spring) 2009;17:1872-1877
71. Nestel PJ, Whyte HM. Plasma free fatty acid and triglyceride turnover in obesity. Metabolism 1968;17:1122-1128
72. Reeds DN, Stuart CA, Perez O, Klein S. Adipose tissue, hepatic, and skeletal muscle insulin sensitivity in extremely obese subjects with acanthosis nigricans. Metabolism 2006;55:1658-1663 (Pubitemid 44830136)
73. Hagenfeldt L. Turnover of individual free fatty acids in man. Fed Proc 1975;34:2246-2249
74. Jensen MD. Adipose tissue and fatty acid metabolism in humans. J R Soc Med 2002;95(Suppl. 42):3-7 (Pubitemid 34876137)
75. Bickerton AS, Roberts R, Fielding BA, et al. Preferential uptake of dietary fatty acids in adipose tissue and muscle in the postprandial period. Diabetes 2007;56:168-176
76. Golay A, Swislocki AL, Chen Y-DI, Jaspan JB, Reaven GM. Effect of obesity on ambient plasma glucose, free fatty acid, insulin, growth hormone, and glucagon concentrations. J Clin Endocrinol Metab 1986;63:481-484 (Pubitemid 16035701)
77. Heptulla R, Smitten A, Teague B, Tamborlane WV, Ma Y-Z, Caprio S. Temporal patterns of circulating leptin levels in lean and obese adolescents: relationships to insulin, growth hormone, and free fatty acids rhythmicity. J Clin Endocrinol Metab 2001;86:90-96 (Pubitemid 32109780)
78. Hernandez TL, Sutherland JP, Wolfe P, et al. Lack of suppression of circulating free fatty acids and hypercholesterolemia during weight loss on a high-fat, low-carbohydrate diet. Am J Clin Nutr 2010;91:578-585
79. Rosenthal MJ, Woodside WF. Nocturnal regulation of free fatty acids in healthy young and elderly men. Metabolism 1988;37:645-648
80. Tan GD, Savage DB, Fielding BA, et al. Fatty acid metabolism in patients with PPARgamma mutations. J Clin Endocrinol Metab 2008;93:4462-4470 (Pubitemid 352789548)
81. McQuaid SE, Humphreys SM, Hodson L, Fielding BA, Karpe F, Frayn KN. Femoral adipose tissue may accumulate the fat that has been recycled as VLDL and nonesterified fatty acids. Diabetes 2010;59:2465-2473
82. Robertson MD, Bickerton AST, Dennis AL, Vidal H, Frayn KN. Insulin-sensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism. Am J Clin Nutr 2005;82:559-567
83. Bickerton AST, Roberts R, Fielding BA, et al. Adipose tissue fatty acid metabolism in insulin-resistant men. Diabetologia 2008;51:1466-1474
84. Tan GD, Fielding BA, Currie JM, et al. The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes. Diabetologia 2005;48:83-95 (Pubitemid 40174660)